• 4572 Citations
  • 37 h-Index
19982019
If you made any changes in Pure these will be visible here soon.

Research Output 1998 2019

Filter
Review article
2019
1 Citation (Scopus)

Definition of treatment-resistant depression – Asia Pacific perspectives

Ng, C. H., Kato, T., Han, C., Wang, G., Trivedi, M., Ramesh, V., Shao, D., Gala, S., Narayanan, S., Tan, W., Feng, Y. & Kasper, S., 2019 Feb 15, In : Journal of Affective Disorders. 245, p. 626-636 11 p.

Research output: Contribution to journalReview article

Open Access
Treatment-Resistant Depressive Disorder
Antidepressive Agents
Consensus
Guidelines
Quality of Life
2018
6 Citations (Scopus)

Efficacy of antidepressants: bias in randomized clinical trials and related issues

Wang, S. M., Han, C., Lee, S. J., Jun, T. Y., Patkar, A. A., Masand, P. S. & Pae, C. U., 2018 Jan 2, In : Expert Review of Clinical Pharmacology. 11, 1, p. 15-25 11 p.

Research output: Contribution to journalReview article

Antidepressive Agents
Randomized Controlled Trials
Clinical Trials
Placebos
Publication Bias
2017
7 Citations (Scopus)

Adjunctive Brexpiprazole as a Novel Effective Strategy for Treating Major Depressive Disorder: A Systematic Review and Meta-Analysis

Yoon, S., Jeon, S. W., Ko, Y-H., Patkar, A. A., Masand, P. S., Pae, C. U. & Han, C., 2017 Feb 1, In : Journal of Clinical Psychopharmacology. 37, 1, p. 46-53 8 p.

Research output: Contribution to journalReview article

Major Depressive Disorder
Meta-Analysis
Confidence Intervals
Psychomotor Agitation
Depression
6 Citations (Scopus)

Comparison between long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia: Systematic review and indirect treatment comparison

Pae, C. U., Wang, S. M., Han, C., Bahk, W. M., Lee, S. J., Patkar, A. A., Masand, P. S., Serretti, A. & Emsley, R., 2017 Jan 1, In : International Clinical Psychopharmacology. 32, 5, p. 235-248 14 p.

Research output: Contribution to journalReview article

Schizophrenia
Injections
Odds Ratio
Confidence Intervals
Antipsychotic Agents
3 Citations (Scopus)

Investigational dopamine antagonists for the treatment of schizophrenia

Wang, S. M., Han, C., Lee, S. J., Jun, T. Y., Patkar, A. A., Masand, P. S. & Pae, C. U., 2017 Jun 3, In : Expert Opinion on Investigational Drugs. 26, 6, p. 687-698 12 p.

Research output: Contribution to journalReview article

Dopamine Antagonists
N-(4-(2-(8-cyano-1,3a,4,9b-tetrahydro(1)benzopyrano(3,4-c)pyrrol-2(3H)-yl)ethyl)phenyl)acetamide
Antipsychotic Agents
Schizophrenia
Investigational Drugs
2016
5 Citations (Scopus)

Precision medicine for psychopharmacology: a general introduction

Shin, C., Han, C., Pae, C. U. & Patkar, A. A., 2016 Jul 2, In : Expert Review of Neurotherapeutics. 16, 7, p. 831-839 9 p.

Research output: Contribution to journalReview article

Psychopharmacology
Precision Medicine
Connectome
Biomedical Technology
Metabolomics
2015
7 Citations (Scopus)

Criticisms of drugs in early development for the treatment of depression: What can be improved?

Wang, S. M., Han, C. & Pae, C. U., 2015 Apr 1, In : Expert Opinion on Investigational Drugs. 24, 4, p. 445-453 9 p.

Research output: Contribution to journalReview article

Antidepressive Agents
Depression
Pharmaceutical Preparations
Major Depressive Disorder
alpha-((5-fluoro-2-methoxyphenyl)methyl)-alpha-(tetrahydro-2H-pyran-4-yl)-2-morpholinemethanol
4 Citations (Scopus)

Fibromyalgia diagnosis: A review of the past, present and future

Wang, S. M., Han, C., Lee, S. J., Patkar, A. A., Masand, P. S. & Pae, C. U., 2015 Jan 1, In : Expert Review of Neurotherapeutics. 15, 6, p. 667-679 13 p.

Research output: Contribution to journalReview article

Fibromyalgia
Medicalization
Comorbidity
Biomarkers
History
2 Citations (Scopus)

Five potential therapeutic agents as antidepressants: A brief review and future directions

Wang, S. M., Han, C., Lee, S. J., Patkar, A. A., Masand, P. S. & Pae, C. U., 2015 Jan 1, In : Expert Review of Neurotherapeutics. 15, 9, p. 1015-1029 15 p.

Research output: Contribution to journalReview article

Antidepressive Agents
Therapeutics
Acetylcarnitine
Serotonin Antagonists
Scopolamine Hydrobromide
16 Citations (Scopus)

Vilazodone for the treatment of major depressive disorder: Focusing on its clinical studies and mechanism of action

Wang, S. M., Han, C., Lee, S. J., Patkar, A. A., Masand, P. S. & Pae, C. U., 2015 Jan 1, In : Psychiatry Investigation. 12, 2, p. 155-163 9 p.

Research output: Contribution to journalReview article

Major Depressive Disorder
Antidepressive Agents
Therapeutics
Serotonin
Phase III Clinical Trials
30 Citations (Scopus)

Vortioxetine, a multimodal antidepressant for generalized anxiety disorder: A systematic review and meta-analysis

Pae, C. U., Wang, S. M., Han, C., Lee, S. J., Patkar, A. A., Masand, P. S. & Serretti, A., 2015 May 1, In : Journal of Psychiatric Research. 64, p. 88-98 11 p.

Research output: Contribution to journalReview article

Anxiety Disorders
Antidepressive Agents
Meta-Analysis
Odds Ratio
Placebos
14 Citations (Scopus)

World federation of societies of biological psychiatry guidelines for the pharmacological treatment of dementias in primary care

WFSBP Task Force on Mental Disorders in Primary Care & WFSBP Task Force on Dementia, 2015 Mar 1, In : International Journal of Psychiatry in Clinical Practice. 19, 1, p. 2-7 6 p.

Research output: Contribution to journalReview article

Biological Psychiatry
Dementia
Primary Health Care
Pharmacology
Guidelines
2014
8 Citations (Scopus)

Antidepressant and QT interval prolongation, how should we look at this issue? Focus on citalopram

Pae, C. U., Wang, S. M., Lee, S. J., Han, C., Patkar, A. A. & Masand, P. S., 2014 Feb 1, In : Expert Opinion on Drug Safety. 13, 2, p. 197-205 9 p.

Research output: Contribution to journalReview article

Citalopram
Antidepressive Agents
Safety
Tricyclic Antidepressive Agents
Psychotropic Drugs
43 Citations (Scopus)

A review of current evidence for acetyl-l-carnitine in the treatment of depression

Wang, S. M., Han, C., Lee, S. J., Patkar, A. A., Masand, P. S. & Pae, C. U., 2014 Jan 1, In : Journal of Psychiatric Research. 53, 1, p. 30-37 8 p.

Research output: Contribution to journalReview article

Acetylcarnitine
Depression
Antidepressive Agents
Dysthymic Disorder
Fluoxetine
3 Citations (Scopus)

Schizophrenia relapse and the clinical usefulness of once-monthly aripiprazole depot injection

Wang, S. M., Han, C., Lee, S. J., Patkar, A. A., Masand, P. S. & Pae, C. U., 2014 Aug 30, In : Neuropsychiatric Disease and Treatment. 10, p. 1605-1611 7 p.

Research output: Contribution to journalReview article

Antipsychotic Agents
Schizophrenia
Recurrence
Injections
Cytochrome P-450 CYP2D6
17 Citations (Scopus)

The potential role of atypical antipsychotics for the treatment of posttraumatic stress disorder

Han, C., Pae, C. U., Wang, S. M., Lee, S. J., Patkar, A. A., Masand, P. S. & Serretti, A., 2014 Jan 1, In : Journal of Psychiatric Research. 56, 1, p. 72-81 10 p.

Research output: Contribution to journalReview article

Post-Traumatic Stress Disorders
Antipsychotic Agents
Randomized Controlled Trials
Meta-Analysis
Therapeutics
2013
11 Citations (Scopus)

Aripiprazole augmentation for treatment of patients with chronic or recurrent major depressive disorder: A 12-week prospective open-label multicentre study

Pae, C. U., Jeon, H. J., Lee, B. C., Seo, H. J., Kim, S. G., Park, E. J., Kim, W., Kwak, K. P., Han, C., Cho, S. J., Hahn, S. W., Jon, D. I., Choi, J. H. & Jun, T. Y., 2013 Nov 1, In : International Clinical Psychopharmacology. 28, 6, p. 322-329 8 p.

Research output: Contribution to journalReview article

compound A 12
Major Depressive Disorder
Multicenter Studies
Patient Participation
Therapeutics
16 Citations (Scopus)

Asenapine, blonanserin, iloperidone, lurasidone, and sertindole: Distinctive clinical characteristics of 5 novel atypical antipsychotics

Wang, S. M., Han, C., Lee, S. J., Patkar, A. A., Masand, P. S. & Pae, C. U., 2013 Nov 1, In : Clinical Neuropharmacology. 36, 6, p. 223-238 16 p.

Research output: Contribution to journalReview article

Antipsychotic Agents
Schizophrenia
Therapeutics
Safety
Neurobehavioral Manifestations
8 Citations (Scopus)

Atypical antipsychotics as a possible treatment option for irritable bowel syndrome

Pae, C. U., Lee, S. J., Han, C., Patkar, A. A. & Masand, P. S., 2013 May 1, In : Expert Opinion on Investigational Drugs. 22, 5, p. 565-572 8 p.

Research output: Contribution to journalReview article

Irritable Bowel Syndrome
Antipsychotic Agents
Tricyclic Antidepressive Agents
Therapeutics
Antidepressive Agents
4 Citations (Scopus)

Diagnosis and treatment of dementia in primary care

Jeong, H-G. & Han, C., 2013 Dec 1, In : Journal of the Korean Medical Association. 56, 12, p. 1104-1112 9 p.

Research output: Contribution to journalReview article

Dementia
Primary Health Care
Primary Care Physicians
Therapeutics
Social Work
9 Citations (Scopus)

Do we need to consider ethno-cultural variation in the use of atypical antipsychotics for asian patients with major depressive disorder?

Han, C. & Pae, C. U., 2013 May 1, In : CNS Drugs. 27, SUPPL.1

Research output: Contribution to journalReview article

Major Depressive Disorder
Antipsychotic Agents
Patient Compliance
Prescriptions
Pharmacokinetics
17 Citations (Scopus)

Evidence for the benefits of nonantipsychotic pharmacological augmentation in the treatment of depression

Chang, C. M., Sato, S. & Han, C., 2013 May 1, In : CNS Drugs. 27, SUPPL.1

Research output: Contribution to journalReview article

Treatment-Resistant Depressive Disorder
Antipsychotic Agents
Pharmacology
Depression
Buspirone
11 Citations (Scopus)

Management of chronic depressive patients with residual symptoms

Han, C., Yeh, T. L., Kato, M., Sato, S., Chang, C. M. & Pae, C. U., 2013 May 1, In : CNS Drugs. 27, SUPPL.1

Research output: Contribution to journalReview article

Major Depressive Disorder
Antidepressive Agents
Recurrence
Case Management
Decision Making
4 Citations (Scopus)

Oral scopolamine augmentation for major depression

Han, C. & Pae, C. U., 2013 Jan 1, In : Expert Review of Neurotherapeutics. 13, 1, p. 19-21 3 p.

Research output: Contribution to journalReview article

Scopolamine Hydrobromide
Antidepressive Agents
Major Depressive Disorder
Depression
Therapeutics
50 Citations (Scopus)

Second-generation antipsychotics in the treatment of major depressive disorder: Current evidence

Han, C., Wang, S. M., Kato, M., Lee, S. J., Patkar, A. A., Masand, P. S. & Pae, C. U., 2013 Sep 3, In : Expert Review of Neurotherapeutics. 13, 7, p. 851-870 20 p.

Research output: Contribution to journalReview article

Major Depressive Disorder
Antidepressive Agents
Antipsychotic Agents
olanzapine
Therapeutics
2012

Association of chronic divalproex sodium use and brain atrophy in Alzheimer's disease

Han, C., Shim, D. S., Lee, S. J., Patkar, A. A., Masand, P. S. & Pae, C. U., 2012 Feb 1, In : Expert Review of Neurotherapeutics. 12, 2, p. 155-158 4 p.

Research output: Contribution to journalReview article

Valproic Acid
Atrophy
Alzheimer Disease
Brain
Neuroprotective Agents
9 Citations (Scopus)

Can botulinum toxin improve mood in depressed patients?

Han, C., Park, G. Y., Wang, S. M., Lee, S. Y., Lee, S. J., Bahk, W. M. & Pae, C. U., 2012 Sep 1, In : Expert Review of Neurotherapeutics. 12, 9, p. 1049-1051 3 p.

Research output: Contribution to journalReview article

Botulinum Toxins
Depression
Facial Expression
Muscles
Emotions
14 Citations (Scopus)

Paliperidone: A review of clinical trial data and clinical implications

Wang, S. M., Han, C., Lee, S. J., Patkar, A. A., Pae, C. U. & Fleischhacker, W. W., 2012 Jul 12, In : Clinical Drug Investigation. 32, 8, p. 497-512 16 p.

Research output: Contribution to journalReview article

Clinical Trials
Psychotic Disorders
Placebos
Risperidone
Schizophrenia
2011
7 Citations (Scopus)

Available therapies and current management of fibromyalgia: Fcusing on pharmacological agents

Han, C., Lee, S. J., Lee, S. Y., Seo, H. J., Wang, S. M., Park, M. H., Patkar, A. A., Koh, J., Masand, P. S. & Pae, C. U., 2011 Jul 1, In : Drugs of Today. 47, 7, p. 539-557 19 p.

Research output: Contribution to journalReview article

Fibromyalgia
Pharmacology
Hypnotics and Sedatives
Anticonvulsants
Therapeutics
33 Citations (Scopus)

Safety and tolerability of lamotrigine: Results from 12 placebo-controlled clinical trials and clinical implications

Seo, H. J., Chiesa, A., Lee, S. J., Patkar, A. A., Han, C., Masand, P. S., Serretti, A. & Pae, C. U., 2011 Jan 1, In : Clinical Neuropharmacology. 34, 1, p. 39-47 9 p.

Research output: Contribution to journalReview article

Controlled Clinical Trials
Placebos
Safety
Bipolar Disorder
Therapeutics
2009
10 Citations (Scopus)

Desvenlafaxine, a serotonin-norepinephrine uptake inhibitor for major depressive disorder, neuropathic pain and the vasomotor symptoms associated with menopause

Pae, C. U., Park, M. H., Marks, D. M., Han, C., Patkar, A. A. & Masand, P. S., 2009 Jan 1, In : Current Opinion in Investigational Drugs. 10, 1, p. 75-90 16 p.

Research output: Contribution to journalReview article

Major Depressive Disorder
Neuralgia
Menopause
Cytochrome P-450 Enzyme System
Antidepressive Agents
2008
8 Citations (Scopus)

Delirium: Underrecognized and undertreated

Pae, C. U., Marks, D. M., Han, C., Patkar, A. A. & Masand, P., 2008 Dec 1, In : Current Treatment Options in Neurology. 10, 5, p. 386-395 10 p.

Research output: Contribution to journalReview article

Delirium
Critical Care
Research
Health Care Costs
Cognition
5 Citations (Scopus)

Delirium: Where do we stand?

Pae, C. U., Marks, D. M., Han, C., Patkar, A. A. & Masand, P., 2008 Jun 1, In : Current Psychiatry Reports. 10, 3, p. 240-248 9 p.

Research output: Contribution to journalReview article

Delirium
Research
Translational Medical Research
Critical Care
Antipsychotic Agents
5 Citations (Scopus)

Mental health economics, health service provision, and the practice of geriatric psychiatry

Suh, G. H. & Han, C., 2008 Nov 1, In : Current Opinion in Psychiatry. 21, 6, p. 546-550 5 p.

Research output: Contribution to journalReview article

Geriatric Psychiatry
Health Services
Cost-Benefit Analysis
Mental Health
Economics
44 Citations (Scopus)

The relationship between fibromyalgia and major depressive disorder: A comprehensive review

Pae, C. U., Luyten, P., Marks, D. M., Han, C., Park, S. H., Patkar, A. A., Masand, P. S. & van Houdenhove, B., 2008 Aug 1, In : Current Medical Research and Opinion. 24, 8, p. 2359-2371 13 p.

Research output: Contribution to journalReview article

Fibromyalgia
Major Depressive Disorder
Psychology
Therapeutics
PubMed
2007
45 Citations (Scopus)

Fatigue as a core symptom in major depressive disorder: Overview and the role of bupropion

Pae, C. U., Lim, H. K., Han, C., Patkar, A. A., Steffens, D. C., Masand, P. S. & Lee, C., 2007 Oct 1, In : Expert Review of Neurotherapeutics. 7, 10, p. 1251-1263 13 p.

Research output: Contribution to journalReview article

Bupropion
Major Depressive Disorder
Fatigue
Antidepressive Agents
Pharmacology
26 Citations (Scopus)

Selegiline transdermal system: Current awareness and promise

Pae, C. U., Lim, H. K., Han, C., Neena, A., Lee, C. & Patkar, A. A., 2007 Aug 15, In : Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31, 6, p. 1153-1163 11 p.

Research output: Contribution to journalReview article

Selegiline
Major Depressive Disorder
Monoamine Oxidase
Tyramine
Monoamine Oxidase Inhibitors